A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 13885 participants.
Also called NCT01732822
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 13,885 participants
- Sponsor
- Registry
-
NCT01732822 -
2011-004616-36
-
- Other papers using this trial's data
- Acute Limb Ischemia in Peripheral Artery Disease
- Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial
- Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial
- Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial
- Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial
- Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial
- Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial
- Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial
- Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial
- Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial
- Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease
- Stroke in Patients With Peripheral Artery Disease
- Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease
- Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
- Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial
- Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Brazil, Bulgaria, Canada, Chile, China, Czechia, France, Germany, Hungary, Italy, Japan, Mexico, Netherlands, Philippines, Poland, Romania, Russia, Slovakia, South Korea, Spain, Sweden, Thailand, Türkiye, Ukraine, United Kingdom, Vietnam
- Registry status
- Completed
Technical summary
Registry record NCT01732822. Randomized; quadruple masking; primary purpose prevention. Start 2012-12-04 (actual); primary completion 2016-09-26 (actual). Results posted on 2017-10-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
- Acronym
- EUCLID
- Condition
- Peripheral Artery Disease
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct01732822- Content hash
a8be3f432d0a368fae7d6a349a9282b54cf58787e02d4f9e1b24234f859eecc7